nodes	percent_of_prediction	percent_of_DWPC	metapath
Nifedipine—ABCC3—Vincristine—muscle cancer	0.084	0.111	CbGbCtD
Nifedipine—ABCC3—Etoposide—muscle cancer	0.077	0.102	CbGbCtD
Nifedipine—CYP1A1—Dacarbazine—muscle cancer	0.0597	0.0787	CbGbCtD
Nifedipine—ABCC3—Doxorubicin—muscle cancer	0.0525	0.0693	CbGbCtD
Nifedipine—ABCC3—Methotrexate—muscle cancer	0.0509	0.0671	CbGbCtD
Nifedipine—CYP2E1—Dacarbazine—muscle cancer	0.0461	0.0608	CbGbCtD
Nifedipine—ABCC2—Vincristine—muscle cancer	0.0382	0.0504	CbGbCtD
Nifedipine—ABCC2—Etoposide—muscle cancer	0.035	0.0462	CbGbCtD
Nifedipine—CYP1A2—Dacarbazine—muscle cancer	0.0267	0.0352	CbGbCtD
Nifedipine—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0255	0.0336	CbGbCtD
Nifedipine—CYP3A7—Vincristine—muscle cancer	0.0255	0.0336	CbGbCtD
Nifedipine—ABCC2—Doxorubicin—muscle cancer	0.0239	0.0315	CbGbCtD
Nifedipine—ABCC2—Methotrexate—muscle cancer	0.0231	0.0305	CbGbCtD
Nifedipine—CYP2E1—Etoposide—muscle cancer	0.0226	0.0298	CbGbCtD
Nifedipine—CACNA1S—pes—muscle cancer	0.0205	0.296	CbGeAlD
Nifedipine—ABCB1—Dactinomycin—muscle cancer	0.0202	0.0267	CbGbCtD
Nifedipine—CYP3A5—Vincristine—muscle cancer	0.0191	0.0252	CbGbCtD
Nifedipine—CYP3A5—Etoposide—muscle cancer	0.0175	0.0231	CbGbCtD
Nifedipine—CYP2C8—Etoposide—muscle cancer	0.0168	0.0222	CbGbCtD
Nifedipine—CYP2B6—Doxorubicin—muscle cancer	0.0152	0.02	CbGbCtD
Nifedipine—CYP1A2—Etoposide—muscle cancer	0.013	0.0172	CbGbCtD
Nifedipine—ABCB1—Vincristine—muscle cancer	0.0124	0.0164	CbGbCtD
Nifedipine—ABCB1—Etoposide—muscle cancer	0.0114	0.0151	CbGbCtD
Nifedipine—ABCB1—Doxorubicin—muscle cancer	0.00778	0.0103	CbGbCtD
Nifedipine—ABCB1—Methotrexate—muscle cancer	0.00754	0.00994	CbGbCtD
Nifedipine—CYP3A4—Vincristine—muscle cancer	0.00746	0.00984	CbGbCtD
Nifedipine—CYP2D6—Doxorubicin—muscle cancer	0.00733	0.00967	CbGbCtD
Nifedipine—CYP3A4—Etoposide—muscle cancer	0.00683	0.00902	CbGbCtD
Nifedipine—CYP3A4—Doxorubicin—muscle cancer	0.00466	0.00615	CbGbCtD
Nifedipine—CACNA1S—tendon—muscle cancer	0.00157	0.0227	CbGeAlD
Nifedipine—CACNA1H—smooth muscle tissue—muscle cancer	0.00133	0.0192	CbGeAlD
Nifedipine—KCNA1—tendon—muscle cancer	0.00123	0.0178	CbGeAlD
Nifedipine—CACNB2—cardiac atrium—muscle cancer	0.00108	0.0156	CbGeAlD
Nifedipine—KCNA1—head—muscle cancer	0.00106	0.0153	CbGeAlD
Nifedipine—CACNA1C—smooth muscle tissue—muscle cancer	0.00101	0.0146	CbGeAlD
Nifedipine—CACNA1D—cardiac atrium—muscle cancer	0.000946	0.0137	CbGeAlD
Nifedipine—CACNB2—tendon—muscle cancer	0.000943	0.0136	CbGeAlD
Nifedipine—ABCC3—renal system—muscle cancer	0.000887	0.0128	CbGeAlD
Nifedipine—CACNA2D1—tendon—muscle cancer	0.000886	0.0128	CbGeAlD
Nifedipine—CACNB2—vagina—muscle cancer	0.000875	0.0126	CbGeAlD
Nifedipine—CACNA1C—cardiac atrium—muscle cancer	0.000873	0.0126	CbGeAlD
Nifedipine—CACNA2D1—bone marrow—muscle cancer	0.000858	0.0124	CbGeAlD
Nifedipine—CALM3—smooth muscle tissue—muscle cancer	0.000848	0.0123	CbGeAlD
Nifedipine—CALM2—embryo—muscle cancer	0.000847	0.0122	CbGeAlD
Nifedipine—CALM1—embryo—muscle cancer	0.000843	0.0122	CbGeAlD
Nifedipine—CACNA1H—testis—muscle cancer	0.000827	0.0119	CbGeAlD
Nifedipine—CACNA2D1—vagina—muscle cancer	0.000822	0.0119	CbGeAlD
Nifedipine—CACNB2—head—muscle cancer	0.000808	0.0117	CbGeAlD
Nifedipine—CACNB2—testis—muscle cancer	0.000781	0.0113	CbGeAlD
Nifedipine—CACNA2D1—head—muscle cancer	0.000759	0.011	CbGeAlD
Nifedipine—CACNA2D1—testis—muscle cancer	0.000733	0.0106	CbGeAlD
Nifedipine—CALM3—cardiac atrium—muscle cancer	0.000731	0.0106	CbGeAlD
Nifedipine—ABCC2—renal system—muscle cancer	0.000709	0.0102	CbGeAlD
Nifedipine—CACNA1D—head—muscle cancer	0.000707	0.0102	CbGeAlD
Nifedipine—CACNA1C—vagina—muscle cancer	0.000706	0.0102	CbGeAlD
Nifedipine—CYP2A6—vagina—muscle cancer	0.000686	0.00991	CbGeAlD
Nifedipine—CACNA1D—testis—muscle cancer	0.000683	0.00986	CbGeAlD
Nifedipine—CALM2—smooth muscle tissue—muscle cancer	0.000666	0.00962	CbGeAlD
Nifedipine—CALM1—smooth muscle tissue—muscle cancer	0.000663	0.00958	CbGeAlD
Nifedipine—CACNA1C—head—muscle cancer	0.000652	0.00942	CbGeAlD
Nifedipine—CALM2—renal system—muscle cancer	0.000641	0.00927	CbGeAlD
Nifedipine—CALM1—renal system—muscle cancer	0.000638	0.00922	CbGeAlD
Nifedipine—CALM3—tendon—muscle cancer	0.000637	0.00921	CbGeAlD
Nifedipine—CACNA1C—testis—muscle cancer	0.00063	0.0091	CbGeAlD
Nifedipine—CALM3—bone marrow—muscle cancer	0.000617	0.00892	CbGeAlD
Nifedipine—ABCC3—head—muscle cancer	0.000593	0.00857	CbGeAlD
Nifedipine—CALM3—vagina—muscle cancer	0.000591	0.00855	CbGeAlD
Nifedipine—CALM2—cardiac atrium—muscle cancer	0.000574	0.0083	CbGeAlD
Nifedipine—ABCC3—testis—muscle cancer	0.000573	0.00828	CbGeAlD
Nifedipine—CALM1—cardiac atrium—muscle cancer	0.000572	0.00826	CbGeAlD
Nifedipine—ABCC2—tendon—muscle cancer	0.000553	0.00799	CbGeAlD
Nifedipine—CYP2C8—renal system—muscle cancer	0.000531	0.00768	CbGeAlD
Nifedipine—CALM3—testis—muscle cancer	0.000528	0.00763	CbGeAlD
Nifedipine—CALM2—tendon—muscle cancer	0.000501	0.00723	CbGeAlD
Nifedipine—CALM1—tendon—muscle cancer	0.000498	0.0072	CbGeAlD
Nifedipine—CYP1A2—renal system—muscle cancer	0.000497	0.00719	CbGeAlD
Nifedipine—CYP1A1—renal system—muscle cancer	0.000491	0.00709	CbGeAlD
Nifedipine—CALM2—bone marrow—muscle cancer	0.000485	0.00701	CbGeAlD
Nifedipine—CALM1—bone marrow—muscle cancer	0.000483	0.00697	CbGeAlD
Nifedipine—CYP3A5—renal system—muscle cancer	0.00048	0.00693	CbGeAlD
Nifedipine—CYP2B6—renal system—muscle cancer	0.000477	0.00689	CbGeAlD
Nifedipine—CALM2—vagina—muscle cancer	0.000464	0.00671	CbGeAlD
Nifedipine—CALM1—vagina—muscle cancer	0.000462	0.00668	CbGeAlD
Nifedipine—ABCC2—testis—muscle cancer	0.000458	0.00662	CbGeAlD
Nifedipine—CYP2E1—renal system—muscle cancer	0.000447	0.00646	CbGeAlD
Nifedipine—CYP1A1—cardiac atrium—muscle cancer	0.000439	0.00635	CbGeAlD
Nifedipine—CALM2—head—muscle cancer	0.000429	0.0062	CbGeAlD
Nifedipine—CALM1—head—muscle cancer	0.000427	0.00617	CbGeAlD
Nifedipine—CALM2—testis—muscle cancer	0.000414	0.00599	CbGeAlD
Nifedipine—CALM1—testis—muscle cancer	0.000413	0.00596	CbGeAlD
Nifedipine—CYP2C8—vagina—muscle cancer	0.000385	0.00556	CbGeAlD
Nifedipine—CYP3A4—renal system—muscle cancer	0.00036	0.0052	CbGeAlD
Nifedipine—CYP1A1—vagina—muscle cancer	0.000355	0.00513	CbGeAlD
Nifedipine—CYP2D6—renal system—muscle cancer	0.000354	0.00512	CbGeAlD
Nifedipine—CYP2E1—tendon—muscle cancer	0.000349	0.00505	CbGeAlD
Nifedipine—CYP3A5—vagina—muscle cancer	0.000347	0.00502	CbGeAlD
Nifedipine—CYP2B6—vagina—muscle cancer	0.000345	0.00499	CbGeAlD
Nifedipine—CYP2C8—testis—muscle cancer	0.000344	0.00496	CbGeAlD
Nifedipine—ABCB1—embryo—muscle cancer	0.000337	0.00486	CbGeAlD
Nifedipine—CYP1A1—head—muscle cancer	0.000328	0.00474	CbGeAlD
Nifedipine—CYP2B6—head—muscle cancer	0.000319	0.00461	CbGeAlD
Nifedipine—CYP2B6—testis—muscle cancer	0.000308	0.00445	CbGeAlD
Nifedipine—CYP2E1—head—muscle cancer	0.000299	0.00432	CbGeAlD
Nifedipine—CYP2E1—testis—muscle cancer	0.000289	0.00418	CbGeAlD
Nifedipine—ABCB1—renal system—muscle cancer	0.000255	0.00368	CbGeAlD
Nifedipine—CYP2D6—head—muscle cancer	0.000237	0.00342	CbGeAlD
Nifedipine—CYP2D6—testis—muscle cancer	0.000229	0.00331	CbGeAlD
Nifedipine—Chest pain—Etoposide—muscle cancer	0.000219	0.00182	CcSEcCtD
Nifedipine—Eosinophilia—Methotrexate—muscle cancer	0.000219	0.00182	CcSEcCtD
Nifedipine—Migraine—Doxorubicin—muscle cancer	0.000218	0.00181	CcSEcCtD
Nifedipine—Affect lability—Doxorubicin—muscle cancer	0.000218	0.00181	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000218	0.0018	CcSEcCtD
Nifedipine—Discomfort—Etoposide—muscle cancer	0.000217	0.0018	CcSEcCtD
Nifedipine—Face oedema—Doxorubicin—muscle cancer	0.000214	0.00177	CcSEcCtD
Nifedipine—Hypersensitivity—Dactinomycin—muscle cancer	0.000214	0.00177	CcSEcCtD
Nifedipine—Abdominal discomfort—Methotrexate—muscle cancer	0.000212	0.00176	CcSEcCtD
Nifedipine—Gastrointestinal pain—Vincristine—muscle cancer	0.000212	0.00176	CcSEcCtD
Nifedipine—Confusional state—Etoposide—muscle cancer	0.000212	0.00176	CcSEcCtD
Nifedipine—Cardiac arrest—Doxorubicin—muscle cancer	0.000211	0.00175	CcSEcCtD
Nifedipine—Anaphylactic shock—Etoposide—muscle cancer	0.00021	0.00174	CcSEcCtD
Nifedipine—Mood swings—Doxorubicin—muscle cancer	0.00021	0.00174	CcSEcCtD
Nifedipine—Ataxia—Doxorubicin—muscle cancer	0.000209	0.00173	CcSEcCtD
Nifedipine—Asthenia—Dactinomycin—muscle cancer	0.000209	0.00173	CcSEcCtD
Nifedipine—Dysuria—Methotrexate—muscle cancer	0.000207	0.00172	CcSEcCtD
Nifedipine—Thrombocytopenia—Etoposide—muscle cancer	0.000206	0.00171	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000206	0.00171	CcSEcCtD
Nifedipine—Tachycardia—Etoposide—muscle cancer	0.000205	0.0017	CcSEcCtD
Nifedipine—Abdominal pain—Vincristine—muscle cancer	0.000205	0.0017	CcSEcCtD
Nifedipine—Body temperature increased—Vincristine—muscle cancer	0.000205	0.0017	CcSEcCtD
Nifedipine—Liver function test abnormal—Doxorubicin—muscle cancer	0.000205	0.0017	CcSEcCtD
Nifedipine—Skin disorder—Etoposide—muscle cancer	0.000204	0.00169	CcSEcCtD
Nifedipine—Erectile dysfunction—Methotrexate—muscle cancer	0.000204	0.00169	CcSEcCtD
Nifedipine—Hyperhidrosis—Etoposide—muscle cancer	0.000203	0.00168	CcSEcCtD
Nifedipine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000203	0.00168	CcSEcCtD
Nifedipine—Photosensitivity reaction—Methotrexate—muscle cancer	0.000202	0.00168	CcSEcCtD
Nifedipine—Breast disorder—Doxorubicin—muscle cancer	0.000201	0.00166	CcSEcCtD
Nifedipine—Anorexia—Etoposide—muscle cancer	0.0002	0.00166	CcSEcCtD
Nifedipine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.0002	0.00166	CcSEcCtD
Nifedipine—Diarrhoea—Dactinomycin—muscle cancer	0.000199	0.00165	CcSEcCtD
Nifedipine—Hypotension—Etoposide—muscle cancer	0.000197	0.00163	CcSEcCtD
Nifedipine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000196	0.00162	CcSEcCtD
Nifedipine—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.000196	0.00162	CcSEcCtD
Nifedipine—Muscular weakness—Doxorubicin—muscle cancer	0.000196	0.00162	CcSEcCtD
Nifedipine—Abdominal distension—Doxorubicin—muscle cancer	0.000193	0.0016	CcSEcCtD
Nifedipine—ABCB1—bone marrow—muscle cancer	0.000193	0.00278	CbGeAlD
Nifedipine—Conjunctivitis—Methotrexate—muscle cancer	0.000192	0.00159	CcSEcCtD
Nifedipine—Dysphagia—Doxorubicin—muscle cancer	0.000192	0.00159	CcSEcCtD
Nifedipine—Hypersensitivity—Vincristine—muscle cancer	0.000191	0.00158	CcSEcCtD
Nifedipine—Eosinophilia—Doxorubicin—muscle cancer	0.00019	0.00157	CcSEcCtD
Nifedipine—Sweating—Methotrexate—muscle cancer	0.000189	0.00157	CcSEcCtD
Nifedipine—Paraesthesia—Etoposide—muscle cancer	0.000189	0.00156	CcSEcCtD
Nifedipine—Haematuria—Methotrexate—muscle cancer	0.000188	0.00156	CcSEcCtD
Nifedipine—Dyspnoea—Etoposide—muscle cancer	0.000188	0.00155	CcSEcCtD
Nifedipine—Somnolence—Etoposide—muscle cancer	0.000187	0.00155	CcSEcCtD
Nifedipine—Angina pectoris—Doxorubicin—muscle cancer	0.000187	0.00155	CcSEcCtD
Nifedipine—Hepatobiliary disease—Methotrexate—muscle cancer	0.000187	0.00155	CcSEcCtD
Nifedipine—Epistaxis—Methotrexate—muscle cancer	0.000186	0.00154	CcSEcCtD
Nifedipine—Asthenia—Vincristine—muscle cancer	0.000186	0.00154	CcSEcCtD
Nifedipine—Vomiting—Dactinomycin—muscle cancer	0.000185	0.00153	CcSEcCtD
Nifedipine—ABCB1—vagina—muscle cancer	0.000185	0.00267	CbGeAlD
Nifedipine—Agranulocytosis—Methotrexate—muscle cancer	0.000184	0.00153	CcSEcCtD
Nifedipine—Rash—Dactinomycin—muscle cancer	0.000183	0.00152	CcSEcCtD
Nifedipine—Decreased appetite—Etoposide—muscle cancer	0.000183	0.00151	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000182	0.0015	CcSEcCtD
Nifedipine—Fatigue—Etoposide—muscle cancer	0.000181	0.0015	CcSEcCtD
Nifedipine—Pain—Etoposide—muscle cancer	0.00018	0.00149	CcSEcCtD
Nifedipine—Constipation—Etoposide—muscle cancer	0.00018	0.00149	CcSEcCtD
Nifedipine—Dysuria—Doxorubicin—muscle cancer	0.000179	0.00149	CcSEcCtD
Nifedipine—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000178	0.00148	CcSEcCtD
Nifedipine—Haemoglobin—Methotrexate—muscle cancer	0.000178	0.00148	CcSEcCtD
Nifedipine—Diarrhoea—Vincristine—muscle cancer	0.000178	0.00147	CcSEcCtD
Nifedipine—Haemorrhage—Methotrexate—muscle cancer	0.000177	0.00147	CcSEcCtD
Nifedipine—Hepatitis—Methotrexate—muscle cancer	0.000177	0.00147	CcSEcCtD
Nifedipine—Pollakiuria—Doxorubicin—muscle cancer	0.000177	0.00147	CcSEcCtD
Nifedipine—Pharyngitis—Methotrexate—muscle cancer	0.000176	0.00146	CcSEcCtD
Nifedipine—Urinary tract disorder—Methotrexate—muscle cancer	0.000175	0.00145	CcSEcCtD
Nifedipine—Photosensitivity reaction—Doxorubicin—muscle cancer	0.000175	0.00145	CcSEcCtD
Nifedipine—Weight increased—Doxorubicin—muscle cancer	0.000175	0.00145	CcSEcCtD
Nifedipine—Urethral disorder—Methotrexate—muscle cancer	0.000174	0.00144	CcSEcCtD
Nifedipine—Weight decreased—Doxorubicin—muscle cancer	0.000174	0.00144	CcSEcCtD
Nifedipine—Feeling abnormal—Etoposide—muscle cancer	0.000173	0.00144	CcSEcCtD
Nifedipine—Hyperglycaemia—Doxorubicin—muscle cancer	0.000173	0.00143	CcSEcCtD
Nifedipine—Nausea—Dactinomycin—muscle cancer	0.000173	0.00143	CcSEcCtD
Nifedipine—Gastrointestinal pain—Etoposide—muscle cancer	0.000172	0.00142	CcSEcCtD
Nifedipine—Dizziness—Vincristine—muscle cancer	0.000172	0.00142	CcSEcCtD
Nifedipine—Visual impairment—Methotrexate—muscle cancer	0.000171	0.00142	CcSEcCtD
Nifedipine—ABCB1—head—muscle cancer	0.00017	0.00246	CbGeAlD
Nifedipine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00017	0.0014	CcSEcCtD
Nifedipine—Erythema multiforme—Methotrexate—muscle cancer	0.000168	0.00139	CcSEcCtD
Nifedipine—Urticaria—Etoposide—muscle cancer	0.000167	0.00138	CcSEcCtD
Nifedipine—Jaundice—Doxorubicin—muscle cancer	0.000167	0.00138	CcSEcCtD
Nifedipine—Abdominal pain—Etoposide—muscle cancer	0.000166	0.00138	CcSEcCtD
Nifedipine—Body temperature increased—Etoposide—muscle cancer	0.000166	0.00138	CcSEcCtD
Nifedipine—Conjunctivitis—Doxorubicin—muscle cancer	0.000166	0.00138	CcSEcCtD
Nifedipine—Eye disorder—Methotrexate—muscle cancer	0.000166	0.00137	CcSEcCtD
Nifedipine—Tinnitus—Methotrexate—muscle cancer	0.000165	0.00137	CcSEcCtD
Nifedipine—Vomiting—Vincristine—muscle cancer	0.000165	0.00137	CcSEcCtD
Nifedipine—ABCB1—testis—muscle cancer	0.000165	0.00238	CbGeAlD
Nifedipine—Cardiac disorder—Methotrexate—muscle cancer	0.000165	0.00136	CcSEcCtD
Nifedipine—Sweating—Doxorubicin—muscle cancer	0.000164	0.00136	CcSEcCtD
Nifedipine—Rash—Vincristine—muscle cancer	0.000164	0.00136	CcSEcCtD
Nifedipine—Dermatitis—Vincristine—muscle cancer	0.000164	0.00135	CcSEcCtD
Nifedipine—Haematuria—Doxorubicin—muscle cancer	0.000163	0.00135	CcSEcCtD
Nifedipine—Headache—Vincristine—muscle cancer	0.000163	0.00135	CcSEcCtD
Nifedipine—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000162	0.00134	CcSEcCtD
Nifedipine—Epistaxis—Doxorubicin—muscle cancer	0.000161	0.00134	CcSEcCtD
Nifedipine—Angiopathy—Methotrexate—muscle cancer	0.000161	0.00133	CcSEcCtD
Nifedipine—Sinusitis—Doxorubicin—muscle cancer	0.00016	0.00133	CcSEcCtD
Nifedipine—Immune system disorder—Methotrexate—muscle cancer	0.00016	0.00133	CcSEcCtD
Nifedipine—Mediastinal disorder—Methotrexate—muscle cancer	0.00016	0.00132	CcSEcCtD
Nifedipine—Agranulocytosis—Doxorubicin—muscle cancer	0.00016	0.00132	CcSEcCtD
Nifedipine—Chills—Methotrexate—muscle cancer	0.000159	0.00132	CcSEcCtD
Nifedipine—Alopecia—Methotrexate—muscle cancer	0.000157	0.0013	CcSEcCtD
Nifedipine—Bradycardia—Doxorubicin—muscle cancer	0.000156	0.00129	CcSEcCtD
Nifedipine—Mental disorder—Methotrexate—muscle cancer	0.000155	0.00129	CcSEcCtD
Nifedipine—Hypersensitivity—Etoposide—muscle cancer	0.000155	0.00128	CcSEcCtD
Nifedipine—Erythema—Methotrexate—muscle cancer	0.000154	0.00128	CcSEcCtD
Nifedipine—Malnutrition—Methotrexate—muscle cancer	0.000154	0.00128	CcSEcCtD
Nifedipine—Haemoglobin—Doxorubicin—muscle cancer	0.000154	0.00128	CcSEcCtD
Nifedipine—Nausea—Vincristine—muscle cancer	0.000154	0.00128	CcSEcCtD
Nifedipine—Rhinitis—Doxorubicin—muscle cancer	0.000154	0.00128	CcSEcCtD
Nifedipine—Haemorrhage—Doxorubicin—muscle cancer	0.000154	0.00127	CcSEcCtD
Nifedipine—Hepatitis—Doxorubicin—muscle cancer	0.000154	0.00127	CcSEcCtD
Nifedipine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000153	0.00127	CcSEcCtD
Nifedipine—Pharyngitis—Doxorubicin—muscle cancer	0.000152	0.00126	CcSEcCtD
Nifedipine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000152	0.00126	CcSEcCtD
Nifedipine—Oedema peripheral—Doxorubicin—muscle cancer	0.000151	0.00125	CcSEcCtD
Nifedipine—Dysgeusia—Methotrexate—muscle cancer	0.000151	0.00125	CcSEcCtD
Nifedipine—Asthenia—Etoposide—muscle cancer	0.000151	0.00125	CcSEcCtD
Nifedipine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000151	0.00125	CcSEcCtD
Nifedipine—Urethral disorder—Doxorubicin—muscle cancer	0.000151	0.00125	CcSEcCtD
Nifedipine—Back pain—Methotrexate—muscle cancer	0.000149	0.00124	CcSEcCtD
Nifedipine—Pruritus—Etoposide—muscle cancer	0.000149	0.00123	CcSEcCtD
Nifedipine—Visual impairment—Doxorubicin—muscle cancer	0.000148	0.00123	CcSEcCtD
Nifedipine—Vision blurred—Methotrexate—muscle cancer	0.000145	0.00121	CcSEcCtD
Nifedipine—Erythema multiforme—Doxorubicin—muscle cancer	0.000145	0.0012	CcSEcCtD
Nifedipine—Diarrhoea—Etoposide—muscle cancer	0.000144	0.00119	CcSEcCtD
Nifedipine—Eye disorder—Doxorubicin—muscle cancer	0.000144	0.00119	CcSEcCtD
Nifedipine—Ill-defined disorder—Methotrexate—muscle cancer	0.000143	0.00119	CcSEcCtD
Nifedipine—Tinnitus—Doxorubicin—muscle cancer	0.000143	0.00119	CcSEcCtD
Nifedipine—Anaemia—Methotrexate—muscle cancer	0.000143	0.00118	CcSEcCtD
Nifedipine—Cardiac disorder—Doxorubicin—muscle cancer	0.000143	0.00118	CcSEcCtD
Nifedipine—Flushing—Doxorubicin—muscle cancer	0.000143	0.00118	CcSEcCtD
Nifedipine—Angiopathy—Doxorubicin—muscle cancer	0.000139	0.00115	CcSEcCtD
Nifedipine—Malaise—Methotrexate—muscle cancer	0.000139	0.00115	CcSEcCtD
Nifedipine—Dizziness—Etoposide—muscle cancer	0.000139	0.00115	CcSEcCtD
Nifedipine—Immune system disorder—Doxorubicin—muscle cancer	0.000139	0.00115	CcSEcCtD
Nifedipine—Vertigo—Methotrexate—muscle cancer	0.000139	0.00115	CcSEcCtD
Nifedipine—Mediastinal disorder—Doxorubicin—muscle cancer	0.000138	0.00115	CcSEcCtD
Nifedipine—Leukopenia—Methotrexate—muscle cancer	0.000138	0.00114	CcSEcCtD
Nifedipine—Chills—Doxorubicin—muscle cancer	0.000138	0.00114	CcSEcCtD
Nifedipine—Arrhythmia—Doxorubicin—muscle cancer	0.000137	0.00114	CcSEcCtD
Nifedipine—Alopecia—Doxorubicin—muscle cancer	0.000136	0.00112	CcSEcCtD
Nifedipine—Cough—Methotrexate—muscle cancer	0.000135	0.00112	CcSEcCtD
Nifedipine—Mental disorder—Doxorubicin—muscle cancer	0.000135	0.00111	CcSEcCtD
Nifedipine—Vomiting—Etoposide—muscle cancer	0.000134	0.00111	CcSEcCtD
Nifedipine—Erythema—Doxorubicin—muscle cancer	0.000134	0.00111	CcSEcCtD
Nifedipine—Malnutrition—Doxorubicin—muscle cancer	0.000134	0.00111	CcSEcCtD
Nifedipine—Rash—Etoposide—muscle cancer	0.000133	0.0011	CcSEcCtD
Nifedipine—Dermatitis—Etoposide—muscle cancer	0.000132	0.0011	CcSEcCtD
Nifedipine—Headache—Etoposide—muscle cancer	0.000132	0.00109	CcSEcCtD
Nifedipine—Flatulence—Doxorubicin—muscle cancer	0.000132	0.00109	CcSEcCtD
Nifedipine—Chest pain—Methotrexate—muscle cancer	0.000131	0.00109	CcSEcCtD
Nifedipine—Arthralgia—Methotrexate—muscle cancer	0.000131	0.00109	CcSEcCtD
Nifedipine—Myalgia—Methotrexate—muscle cancer	0.000131	0.00109	CcSEcCtD
Nifedipine—Tension—Doxorubicin—muscle cancer	0.000131	0.00109	CcSEcCtD
Nifedipine—Dysgeusia—Doxorubicin—muscle cancer	0.000131	0.00108	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000131	0.00108	CcSEcCtD
Nifedipine—Discomfort—Methotrexate—muscle cancer	0.00013	0.00108	CcSEcCtD
Nifedipine—Nervousness—Doxorubicin—muscle cancer	0.00013	0.00108	CcSEcCtD
Nifedipine—Back pain—Doxorubicin—muscle cancer	0.000129	0.00107	CcSEcCtD
Nifedipine—Muscle spasms—Doxorubicin—muscle cancer	0.000129	0.00106	CcSEcCtD
Nifedipine—Confusional state—Methotrexate—muscle cancer	0.000127	0.00105	CcSEcCtD
Nifedipine—Anaphylactic shock—Methotrexate—muscle cancer	0.000126	0.00104	CcSEcCtD
Nifedipine—Vision blurred—Doxorubicin—muscle cancer	0.000126	0.00104	CcSEcCtD
Nifedipine—Nausea—Etoposide—muscle cancer	0.000125	0.00103	CcSEcCtD
Nifedipine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000124	0.00103	CcSEcCtD
Nifedipine—Nervous system disorder—Methotrexate—muscle cancer	0.000124	0.00102	CcSEcCtD
Nifedipine—Anaemia—Doxorubicin—muscle cancer	0.000124	0.00102	CcSEcCtD
Nifedipine—Thrombocytopenia—Methotrexate—muscle cancer	0.000123	0.00102	CcSEcCtD
Nifedipine—Agitation—Doxorubicin—muscle cancer	0.000123	0.00102	CcSEcCtD
Nifedipine—Skin disorder—Methotrexate—muscle cancer	0.000122	0.00101	CcSEcCtD
Nifedipine—Hyperhidrosis—Methotrexate—muscle cancer	0.000122	0.00101	CcSEcCtD
Nifedipine—Malaise—Doxorubicin—muscle cancer	0.000121	0.000998	CcSEcCtD
Nifedipine—Vertigo—Doxorubicin—muscle cancer	0.00012	0.000995	CcSEcCtD
Nifedipine—Anorexia—Methotrexate—muscle cancer	0.00012	0.000995	CcSEcCtD
Nifedipine—Syncope—Doxorubicin—muscle cancer	0.00012	0.000993	CcSEcCtD
Nifedipine—Leukopenia—Doxorubicin—muscle cancer	0.00012	0.000991	CcSEcCtD
Nifedipine—Palpitations—Doxorubicin—muscle cancer	0.000118	0.000978	CcSEcCtD
Nifedipine—Hypotension—Methotrexate—muscle cancer	0.000118	0.000975	CcSEcCtD
Nifedipine—Loss of consciousness—Doxorubicin—muscle cancer	0.000117	0.000973	CcSEcCtD
Nifedipine—Cough—Doxorubicin—muscle cancer	0.000117	0.000966	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000115	0.000951	CcSEcCtD
Nifedipine—Insomnia—Methotrexate—muscle cancer	0.000114	0.000944	CcSEcCtD
Nifedipine—Myalgia—Doxorubicin—muscle cancer	0.000114	0.000943	CcSEcCtD
Nifedipine—Chest pain—Doxorubicin—muscle cancer	0.000114	0.000943	CcSEcCtD
Nifedipine—Arthralgia—Doxorubicin—muscle cancer	0.000114	0.000943	CcSEcCtD
Nifedipine—Anxiety—Doxorubicin—muscle cancer	0.000113	0.000939	CcSEcCtD
Nifedipine—Paraesthesia—Methotrexate—muscle cancer	0.000113	0.000937	CcSEcCtD
Nifedipine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000113	0.000936	CcSEcCtD
Nifedipine—Discomfort—Doxorubicin—muscle cancer	0.000112	0.000931	CcSEcCtD
Nifedipine—Dyspnoea—Methotrexate—muscle cancer	0.000112	0.00093	CcSEcCtD
Nifedipine—Somnolence—Methotrexate—muscle cancer	0.000112	0.000928	CcSEcCtD
Nifedipine—Dry mouth—Doxorubicin—muscle cancer	0.000111	0.000922	CcSEcCtD
Nifedipine—Dyspepsia—Methotrexate—muscle cancer	0.000111	0.000919	CcSEcCtD
Nifedipine—Confusional state—Doxorubicin—muscle cancer	0.00011	0.000911	CcSEcCtD
Nifedipine—Decreased appetite—Methotrexate—muscle cancer	0.00011	0.000907	CcSEcCtD
Nifedipine—Oedema—Doxorubicin—muscle cancer	0.000109	0.000904	CcSEcCtD
Nifedipine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000109	0.000904	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000109	0.000901	CcSEcCtD
Nifedipine—Fatigue—Methotrexate—muscle cancer	0.000109	0.0009	CcSEcCtD
Nifedipine—Pain—Methotrexate—muscle cancer	0.000108	0.000892	CcSEcCtD
Nifedipine—Shock—Doxorubicin—muscle cancer	0.000107	0.000889	CcSEcCtD
Nifedipine—Nervous system disorder—Doxorubicin—muscle cancer	0.000107	0.000886	CcSEcCtD
Nifedipine—Thrombocytopenia—Doxorubicin—muscle cancer	0.000107	0.000885	CcSEcCtD
Nifedipine—Tachycardia—Doxorubicin—muscle cancer	0.000106	0.000882	CcSEcCtD
Nifedipine—Skin disorder—Doxorubicin—muscle cancer	0.000106	0.000878	CcSEcCtD
Nifedipine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000105	0.000874	CcSEcCtD
Nifedipine—Anorexia—Doxorubicin—muscle cancer	0.000104	0.000861	CcSEcCtD
Nifedipine—Feeling abnormal—Methotrexate—muscle cancer	0.000104	0.00086	CcSEcCtD
Nifedipine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000103	0.000853	CcSEcCtD
Nifedipine—Hypotension—Doxorubicin—muscle cancer	0.000102	0.000844	CcSEcCtD
Nifedipine—Urticaria—Methotrexate—muscle cancer	0.0001	0.000829	CcSEcCtD
Nifedipine—Abdominal pain—Methotrexate—muscle cancer	9.96e-05	0.000825	CcSEcCtD
Nifedipine—Body temperature increased—Methotrexate—muscle cancer	9.96e-05	0.000825	CcSEcCtD
Nifedipine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	9.94e-05	0.000823	CcSEcCtD
Nifedipine—Insomnia—Doxorubicin—muscle cancer	9.87e-05	0.000817	CcSEcCtD
Nifedipine—Paraesthesia—Doxorubicin—muscle cancer	9.8e-05	0.000811	CcSEcCtD
Nifedipine—Dyspnoea—Doxorubicin—muscle cancer	9.73e-05	0.000806	CcSEcCtD
Nifedipine—Somnolence—Doxorubicin—muscle cancer	9.7e-05	0.000803	CcSEcCtD
Nifedipine—Dyspepsia—Doxorubicin—muscle cancer	9.6e-05	0.000795	CcSEcCtD
Nifedipine—Decreased appetite—Doxorubicin—muscle cancer	9.48e-05	0.000786	CcSEcCtD
Nifedipine—Gastrointestinal disorder—Doxorubicin—muscle cancer	9.42e-05	0.00078	CcSEcCtD
Nifedipine—Fatigue—Doxorubicin—muscle cancer	9.41e-05	0.000779	CcSEcCtD
Nifedipine—Constipation—Doxorubicin—muscle cancer	9.33e-05	0.000773	CcSEcCtD
Nifedipine—Pain—Doxorubicin—muscle cancer	9.33e-05	0.000773	CcSEcCtD
Nifedipine—Hypersensitivity—Methotrexate—muscle cancer	9.28e-05	0.000769	CcSEcCtD
Nifedipine—Asthenia—Methotrexate—muscle cancer	9.04e-05	0.000749	CcSEcCtD
Nifedipine—Feeling abnormal—Doxorubicin—muscle cancer	8.99e-05	0.000745	CcSEcCtD
Nifedipine—Gastrointestinal pain—Doxorubicin—muscle cancer	8.92e-05	0.000739	CcSEcCtD
Nifedipine—Pruritus—Methotrexate—muscle cancer	8.91e-05	0.000738	CcSEcCtD
Nifedipine—Urticaria—Doxorubicin—muscle cancer	8.67e-05	0.000718	CcSEcCtD
Nifedipine—Body temperature increased—Doxorubicin—muscle cancer	8.62e-05	0.000714	CcSEcCtD
Nifedipine—Abdominal pain—Doxorubicin—muscle cancer	8.62e-05	0.000714	CcSEcCtD
Nifedipine—Diarrhoea—Methotrexate—muscle cancer	8.62e-05	0.000714	CcSEcCtD
Nifedipine—Dizziness—Methotrexate—muscle cancer	8.33e-05	0.00069	CcSEcCtD
Nifedipine—Hypersensitivity—Doxorubicin—muscle cancer	8.04e-05	0.000666	CcSEcCtD
Nifedipine—Vomiting—Methotrexate—muscle cancer	8.01e-05	0.000664	CcSEcCtD
Nifedipine—Rash—Methotrexate—muscle cancer	7.94e-05	0.000658	CcSEcCtD
Nifedipine—Dermatitis—Methotrexate—muscle cancer	7.94e-05	0.000657	CcSEcCtD
Nifedipine—Headache—Methotrexate—muscle cancer	7.89e-05	0.000654	CcSEcCtD
Nifedipine—Asthenia—Doxorubicin—muscle cancer	7.83e-05	0.000648	CcSEcCtD
Nifedipine—Pruritus—Doxorubicin—muscle cancer	7.72e-05	0.000639	CcSEcCtD
Nifedipine—Nausea—Methotrexate—muscle cancer	7.48e-05	0.00062	CcSEcCtD
Nifedipine—Diarrhoea—Doxorubicin—muscle cancer	7.46e-05	0.000618	CcSEcCtD
Nifedipine—Dizziness—Doxorubicin—muscle cancer	7.21e-05	0.000598	CcSEcCtD
Nifedipine—Vomiting—Doxorubicin—muscle cancer	6.94e-05	0.000575	CcSEcCtD
Nifedipine—Rash—Doxorubicin—muscle cancer	6.88e-05	0.00057	CcSEcCtD
Nifedipine—Dermatitis—Doxorubicin—muscle cancer	6.87e-05	0.000569	CcSEcCtD
Nifedipine—Headache—Doxorubicin—muscle cancer	6.83e-05	0.000566	CcSEcCtD
Nifedipine—Nausea—Doxorubicin—muscle cancer	6.48e-05	0.000537	CcSEcCtD
Nifedipine—CALM2—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	4.42e-05	0.000845	CbGpPWpGaD
Nifedipine—CALM1—VEGFA-VEGFR2 Pathway—VEGFA—muscle cancer	4.42e-05	0.000845	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—FOXO1—muscle cancer	4.42e-05	0.000845	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—FOXO1—muscle cancer	4.42e-05	0.000845	CbGpPWpGaD
Nifedipine—ABCB1—Allograft Rejection—VEGFA—muscle cancer	4.41e-05	0.000844	CbGpPWpGaD
Nifedipine—CALM3—Alzheimers Disease—TP53—muscle cancer	4.4e-05	0.000841	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	4.38e-05	0.000837	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—KIT—muscle cancer	4.38e-05	0.000837	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—MED12—muscle cancer	4.34e-05	0.000831	CbGpPWpGaD
Nifedipine—CALM3—Downstream signal transduction—MDM2—muscle cancer	4.34e-05	0.00083	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR—MDM2—muscle cancer	4.32e-05	0.000826	CbGpPWpGaD
Nifedipine—CALM3—Signaling by VEGF—VEGFA—muscle cancer	4.31e-05	0.000825	CbGpPWpGaD
Nifedipine—CALM3—Signaling by ERBB2—MDM2—muscle cancer	4.3e-05	0.000821	CbGpPWpGaD
Nifedipine—CALM3—DAP12 signaling—MDM2—muscle cancer	4.28e-05	0.000817	CbGpPWpGaD
Nifedipine—CACNA1S—Developmental Biology—VEGFA—muscle cancer	4.27e-05	0.000817	CbGpPWpGaD
Nifedipine—CACNA1C—Axon guidance—VEGFA—muscle cancer	4.27e-05	0.000817	CbGpPWpGaD
Nifedipine—CALM2—Alzheimers Disease—TP53—muscle cancer	4.26e-05	0.000814	CbGpPWpGaD
Nifedipine—CALM1—Alzheimers Disease—TP53—muscle cancer	4.26e-05	0.000814	CbGpPWpGaD
Nifedipine—CALM2—Downstream signal transduction—MDM2—muscle cancer	4.2e-05	0.000803	CbGpPWpGaD
Nifedipine—CALM1—Downstream signal transduction—MDM2—muscle cancer	4.2e-05	0.000803	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR—MDM2—muscle cancer	4.18e-05	0.000799	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR—MDM2—muscle cancer	4.18e-05	0.000799	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.17e-05	0.000798	CbGpPWpGaD
Nifedipine—CALM2—Signaling by VEGF—VEGFA—muscle cancer	4.17e-05	0.000798	CbGpPWpGaD
Nifedipine—CALM1—Signaling by VEGF—VEGFA—muscle cancer	4.17e-05	0.000798	CbGpPWpGaD
Nifedipine—CALM1—Signaling by ERBB2—MDM2—muscle cancer	4.16e-05	0.000795	CbGpPWpGaD
Nifedipine—CALM2—Signaling by ERBB2—MDM2—muscle cancer	4.16e-05	0.000795	CbGpPWpGaD
Nifedipine—CALM2—DAP12 signaling—MDM2—muscle cancer	4.14e-05	0.000791	CbGpPWpGaD
Nifedipine—CALM1—DAP12 signaling—MDM2—muscle cancer	4.14e-05	0.000791	CbGpPWpGaD
Nifedipine—CALM3—DAP12 interactions—MDM2—muscle cancer	4.02e-05	0.000769	CbGpPWpGaD
Nifedipine—CALM3—Signaling by FGFR in disease—MDM2—muscle cancer	4.02e-05	0.000769	CbGpPWpGaD
Nifedipine—CALM3—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	4.02e-05	0.000769	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR—MDM2—muscle cancer	3.99e-05	0.000762	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—ENO2—muscle cancer	3.96e-05	0.000757	CbGpPWpGaD
Nifedipine—CALM3—Signaling by EGFR in Cancer—MDM2—muscle cancer	3.95e-05	0.000755	CbGpPWpGaD
Nifedipine—CALM3—Signaling by PDGF—MDM2—muscle cancer	3.93e-05	0.000752	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KIDINS220—muscle cancer	3.92e-05	0.00075	CbGpPWpGaD
Nifedipine—CALM1—Signaling by FGFR in disease—MDM2—muscle cancer	3.89e-05	0.000744	CbGpPWpGaD
Nifedipine—CALM1—DAP12 interactions—MDM2—muscle cancer	3.89e-05	0.000744	CbGpPWpGaD
Nifedipine—CALM1—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	3.89e-05	0.000744	CbGpPWpGaD
Nifedipine—CALM2—DAP12 interactions—MDM2—muscle cancer	3.89e-05	0.000744	CbGpPWpGaD
Nifedipine—CALM2—Fc epsilon receptor (FCERI) signaling—MDM2—muscle cancer	3.89e-05	0.000744	CbGpPWpGaD
Nifedipine—CALM2—Signaling by FGFR in disease—MDM2—muscle cancer	3.89e-05	0.000744	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—FH—muscle cancer	3.89e-05	0.000743	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR—MDM2—muscle cancer	3.86e-05	0.000737	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR—MDM2—muscle cancer	3.86e-05	0.000737	CbGpPWpGaD
Nifedipine—CALM1—Signaling by EGFR in Cancer—MDM2—muscle cancer	3.82e-05	0.000731	CbGpPWpGaD
Nifedipine—CALM2—Signaling by EGFR in Cancer—MDM2—muscle cancer	3.82e-05	0.000731	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—FH—muscle cancer	3.81e-05	0.000728	CbGpPWpGaD
Nifedipine—CALM2—Signaling by PDGF—MDM2—muscle cancer	3.81e-05	0.000728	CbGpPWpGaD
Nifedipine—CALM1—Signaling by PDGF—MDM2—muscle cancer	3.81e-05	0.000728	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—FH—muscle cancer	3.8e-05	0.000726	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KIDINS220—muscle cancer	3.79e-05	0.000726	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KIDINS220—muscle cancer	3.79e-05	0.000726	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—FH—muscle cancer	3.78e-05	0.000723	CbGpPWpGaD
Nifedipine—CALM3—B Cell Activation—MDM2—muscle cancer	3.72e-05	0.000712	CbGpPWpGaD
Nifedipine—CACNB2—Developmental Biology—VEGFA—muscle cancer	3.66e-05	0.000701	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—FH—muscle cancer	3.66e-05	0.000699	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—FH—muscle cancer	3.66e-05	0.000699	CbGpPWpGaD
Nifedipine—CALM3—Transmission across Chemical Synapses—MDM2—muscle cancer	3.65e-05	0.000697	CbGpPWpGaD
Nifedipine—CALM1—B Cell Activation—MDM2—muscle cancer	3.6e-05	0.000688	CbGpPWpGaD
Nifedipine—CALM2—B Cell Activation—MDM2—muscle cancer	3.6e-05	0.000688	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—FH—muscle cancer	3.59e-05	0.000686	CbGpPWpGaD
Nifedipine—CALM3—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	3.56e-05	0.000681	CbGpPWpGaD
Nifedipine—CALM2—Transmission across Chemical Synapses—MDM2—muscle cancer	3.53e-05	0.000675	CbGpPWpGaD
Nifedipine—CALM1—Transmission across Chemical Synapses—MDM2—muscle cancer	3.53e-05	0.000675	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—FOXO4—muscle cancer	3.53e-05	0.000674	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—KIT—muscle cancer	3.48e-05	0.000665	CbGpPWpGaD
Nifedipine—CACNA1D—Developmental Biology—VEGFA—muscle cancer	3.47e-05	0.000663	CbGpPWpGaD
Nifedipine—CALM2—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	3.45e-05	0.000659	CbGpPWpGaD
Nifedipine—CALM1—NGF signalling via TRKA from the plasma membrane—MDM2—muscle cancer	3.45e-05	0.000659	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—FOXO4—muscle cancer	3.41e-05	0.000652	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—FOXO4—muscle cancer	3.41e-05	0.000652	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.4e-05	0.000649	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—FOXO4—muscle cancer	3.39e-05	0.000647	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—KIT—muscle cancer	3.37e-05	0.000643	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—KIT—muscle cancer	3.37e-05	0.000643	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—FH—muscle cancer	3.29e-05	0.000629	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—FOXO4—muscle cancer	3.28e-05	0.000626	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—FOXO4—muscle cancer	3.28e-05	0.000626	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—IGF2—muscle cancer	3.14e-05	0.000601	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.1e-05	0.000592	CbGpPWpGaD
Nifedipine—CACNA1C—Developmental Biology—VEGFA—muscle cancer	3.05e-05	0.000583	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—IGF2—muscle cancer	3.04e-05	0.000581	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—IGF2—muscle cancer	3.04e-05	0.000581	CbGpPWpGaD
Nifedipine—CALM3—Immune System—CD34—muscle cancer	3.02e-05	0.000578	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—MED12—muscle cancer	2.97e-05	0.000568	CbGpPWpGaD
Nifedipine—CALM1—Immune System—CD34—muscle cancer	2.92e-05	0.000559	CbGpPWpGaD
Nifedipine—CALM2—Immune System—CD34—muscle cancer	2.92e-05	0.000559	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.9e-05	0.000555	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	2.87e-05	0.000548	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—FH—muscle cancer	2.87e-05	0.000548	CbGpPWpGaD
Nifedipine—CALM3—Neuronal System—MDM2—muscle cancer	2.79e-05	0.000534	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	2.76e-05	0.000529	CbGpPWpGaD
Nifedipine—CALM3—Signaling by NGF—MDM2—muscle cancer	2.74e-05	0.000524	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—MED12—muscle cancer	2.72e-05	0.00052	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—ENO2—muscle cancer	2.71e-05	0.000518	CbGpPWpGaD
Nifedipine—CALM2—Neuronal System—MDM2—muscle cancer	2.7e-05	0.000517	CbGpPWpGaD
Nifedipine—CALM1—Neuronal System—MDM2—muscle cancer	2.7e-05	0.000517	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—FH—muscle cancer	2.7e-05	0.000516	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—FH—muscle cancer	2.68e-05	0.000512	CbGpPWpGaD
Nifedipine—CALM1—Signaling by NGF—MDM2—muscle cancer	2.65e-05	0.000507	CbGpPWpGaD
Nifedipine—CALM2—Signaling by NGF—MDM2—muscle cancer	2.65e-05	0.000507	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—PTCH1—muscle cancer	2.61e-05	0.0005	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—FOXO1—muscle cancer	2.6e-05	0.000498	CbGpPWpGaD
Nifedipine—CALM3—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	2.56e-05	0.000489	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—PTCH1—muscle cancer	2.53e-05	0.000483	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—PTCH1—muscle cancer	2.53e-05	0.000483	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—FOXO1—muscle cancer	2.52e-05	0.000482	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—FOXO1—muscle cancer	2.52e-05	0.000482	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—FOXO1—muscle cancer	2.5e-05	0.000478	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—ENO2—muscle cancer	2.48e-05	0.000474	CbGpPWpGaD
Nifedipine—CALM1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	2.47e-05	0.000473	CbGpPWpGaD
Nifedipine—CALM2—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	2.47e-05	0.000473	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—FOXO1—muscle cancer	2.42e-05	0.000463	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—FOXO1—muscle cancer	2.42e-05	0.000463	CbGpPWpGaD
Nifedipine—CALM3—Disease—ENO2—muscle cancer	2.33e-05	0.000445	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—FH—muscle cancer	2.29e-05	0.000437	CbGpPWpGaD
Nifedipine—CALM2—Disease—ENO2—muscle cancer	2.25e-05	0.00043	CbGpPWpGaD
Nifedipine—CALM1—Disease—ENO2—muscle cancer	2.25e-05	0.00043	CbGpPWpGaD
Nifedipine—CALM3—Signaling by GPCR—CNR1—muscle cancer	2.21e-05	0.000422	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—MED12—muscle cancer	2.2e-05	0.00042	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	2.18e-05	0.000416	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—MED12—muscle cancer	2.15e-05	0.000411	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—MED12—muscle cancer	2.15e-05	0.00041	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—MED12—muscle cancer	2.14e-05	0.000409	CbGpPWpGaD
Nifedipine—CALM2—Signaling by GPCR—CNR1—muscle cancer	2.13e-05	0.000408	CbGpPWpGaD
Nifedipine—CALM1—Signaling by GPCR—CNR1—muscle cancer	2.13e-05	0.000408	CbGpPWpGaD
Nifedipine—CALM3—Disease—HMGA1—muscle cancer	2.11e-05	0.000404	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—MED12—muscle cancer	2.07e-05	0.000395	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—MED12—muscle cancer	2.07e-05	0.000395	CbGpPWpGaD
Nifedipine—CALM3—Immune System—FOXO4—muscle cancer	2.05e-05	0.000393	CbGpPWpGaD
Nifedipine—CALM2—Disease—HMGA1—muscle cancer	2.05e-05	0.000391	CbGpPWpGaD
Nifedipine—CALM1—Disease—HMGA1—muscle cancer	2.05e-05	0.000391	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—MED12—muscle cancer	2.03e-05	0.000388	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—ENO2—muscle cancer	2e-05	0.000383	CbGpPWpGaD
Nifedipine—CALM1—Immune System—FOXO4—muscle cancer	1.99e-05	0.00038	CbGpPWpGaD
Nifedipine—CALM2—Immune System—FOXO4—muscle cancer	1.99e-05	0.00038	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—KIT—muscle cancer	1.98e-05	0.000379	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—ENO2—muscle cancer	1.96e-05	0.000375	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—ENO2—muscle cancer	1.96e-05	0.000374	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—ENO2—muscle cancer	1.95e-05	0.000372	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—KIT—muscle cancer	1.92e-05	0.000367	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—KIT—muscle cancer	1.92e-05	0.000367	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—KIT—muscle cancer	1.91e-05	0.000364	CbGpPWpGaD
Nifedipine—CALM3—Disease—FOXO4—muscle cancer	1.9e-05	0.000363	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—ENO2—muscle cancer	1.88e-05	0.00036	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—ENO2—muscle cancer	1.88e-05	0.00036	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—MED12—muscle cancer	1.86e-05	0.000355	CbGpPWpGaD
Nifedipine—CACNB2—Metabolism—PTGS2—muscle cancer	1.85e-05	0.000354	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—ENO2—muscle cancer	1.85e-05	0.000353	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—KIT—muscle cancer	1.84e-05	0.000352	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—KIT—muscle cancer	1.84e-05	0.000352	CbGpPWpGaD
Nifedipine—CALM2—Disease—FOXO4—muscle cancer	1.83e-05	0.000351	CbGpPWpGaD
Nifedipine—CALM1—Disease—FOXO4—muscle cancer	1.83e-05	0.000351	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—FH—muscle cancer	1.77e-05	0.000338	CbGpPWpGaD
Nifedipine—CACNA1D—Metabolism—PTGS2—muscle cancer	1.75e-05	0.000335	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—ENO2—muscle cancer	1.69e-05	0.000324	CbGpPWpGaD
Nifedipine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	1.65e-05	0.000315	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—MED12—muscle cancer	1.62e-05	0.00031	CbGpPWpGaD
Nifedipine—CALM3—Innate Immune System—MDM2—muscle cancer	1.56e-05	0.000299	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—PTCH1—muscle cancer	1.54e-05	0.000295	CbGpPWpGaD
Nifedipine—CACNA1C—Metabolism—PTGS2—muscle cancer	1.54e-05	0.000294	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—MED12—muscle cancer	1.53e-05	0.000292	CbGpPWpGaD
Nifedipine—CALM3—Immune System—FOXO1—muscle cancer	1.52e-05	0.00029	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—MED12—muscle cancer	1.51e-05	0.000289	CbGpPWpGaD
Nifedipine—CALM1—Innate Immune System—MDM2—muscle cancer	1.51e-05	0.000289	CbGpPWpGaD
Nifedipine—CALM2—Innate Immune System—MDM2—muscle cancer	1.51e-05	0.000289	CbGpPWpGaD
Nifedipine—CALM3—Adaptive Immune System—MDM2—muscle cancer	1.5e-05	0.000287	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—PTCH1—muscle cancer	1.49e-05	0.000286	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—PTCH1—muscle cancer	1.49e-05	0.000286	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—ENO2—muscle cancer	1.48e-05	0.000282	CbGpPWpGaD
Nifedipine—CALM1—Immune System—FOXO1—muscle cancer	1.47e-05	0.000281	CbGpPWpGaD
Nifedipine—CALM2—Immune System—FOXO1—muscle cancer	1.47e-05	0.000281	CbGpPWpGaD
Nifedipine—CALM1—Adaptive Immune System—MDM2—muscle cancer	1.45e-05	0.000278	CbGpPWpGaD
Nifedipine—CALM2—Adaptive Immune System—MDM2—muscle cancer	1.45e-05	0.000278	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.45e-05	0.000276	CbGpPWpGaD
Nifedipine—CALM3—Disease—FOXO1—muscle cancer	1.4e-05	0.000268	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—ENO2—muscle cancer	1.39e-05	0.000266	CbGpPWpGaD
Nifedipine—ABCC3—Metabolism—PTGS2—muscle cancer	1.38e-05	0.000264	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—ENO2—muscle cancer	1.38e-05	0.000264	CbGpPWpGaD
Nifedipine—CALM1—Disease—FOXO1—muscle cancer	1.35e-05	0.000259	CbGpPWpGaD
Nifedipine—CALM2—Disease—FOXO1—muscle cancer	1.35e-05	0.000259	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FOXO4—muscle cancer	1.33e-05	0.000254	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.33e-05	0.000253	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—VEGFA—muscle cancer	1.32e-05	0.000252	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—CNR1—muscle cancer	1.3e-05	0.000249	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—MED12—muscle cancer	1.29e-05	0.000247	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FOXO4—muscle cancer	1.28e-05	0.000246	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FOXO4—muscle cancer	1.28e-05	0.000246	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—VEGFA—muscle cancer	1.28e-05	0.000244	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—VEGFA—muscle cancer	1.28e-05	0.000244	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—CNR1—muscle cancer	1.26e-05	0.000241	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—CNR1—muscle cancer	1.26e-05	0.000241	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—ENO2—muscle cancer	1.18e-05	0.000225	CbGpPWpGaD
Nifedipine—CALM3—Immune System—KIT—muscle cancer	1.16e-05	0.000221	CbGpPWpGaD
Nifedipine—CALM2—Immune System—KIT—muscle cancer	1.12e-05	0.000214	CbGpPWpGaD
Nifedipine—CALM1—Immune System—KIT—muscle cancer	1.12e-05	0.000214	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.08e-05	0.000206	CbGpPWpGaD
Nifedipine—CALM3—Disease—KIT—muscle cancer	1.07e-05	0.000204	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—IGF2—muscle cancer	1.07e-05	0.000204	CbGpPWpGaD
Nifedipine—CALM1—Disease—KIT—muscle cancer	1.03e-05	0.000197	CbGpPWpGaD
Nifedipine—CALM2—Disease—KIT—muscle cancer	1.03e-05	0.000197	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—IGF2—muscle cancer	1.03e-05	0.000197	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—IGF2—muscle cancer	1.03e-05	0.000197	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—MED12—muscle cancer	9.98e-06	0.000191	CbGpPWpGaD
Nifedipine—CALM3—Hemostasis—TP53—muscle cancer	9.96e-06	0.00019	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—FOXO1—muscle cancer	9.81e-06	0.000188	CbGpPWpGaD
Nifedipine—CALM2—Hemostasis—TP53—muscle cancer	9.63e-06	0.000184	CbGpPWpGaD
Nifedipine—CALM1—Hemostasis—TP53—muscle cancer	9.63e-06	0.000184	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—FOXO1—muscle cancer	9.49e-06	0.000181	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—FOXO1—muscle cancer	9.49e-06	0.000181	CbGpPWpGaD
Nifedipine—CYP3A7—Metabolism—PTGS2—muscle cancer	9.43e-06	0.00018	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.22e-06	0.000176	CbGpPWpGaD
Nifedipine—CALM3—Immune System—MDM2—muscle cancer	9.1e-06	0.000174	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—ENO2—muscle cancer	9.1e-06	0.000174	CbGpPWpGaD
Nifedipine—CALM2—Immune System—MDM2—muscle cancer	8.8e-06	0.000168	CbGpPWpGaD
Nifedipine—CALM1—Immune System—MDM2—muscle cancer	8.8e-06	0.000168	CbGpPWpGaD
Nifedipine—CYP2A6—Metabolism—PTGS2—muscle cancer	8.64e-06	0.000165	CbGpPWpGaD
Nifedipine—CALM3—Disease—MDM2—muscle cancer	8.4e-06	0.000161	CbGpPWpGaD
Nifedipine—CALM2—Disease—MDM2—muscle cancer	8.13e-06	0.000155	CbGpPWpGaD
Nifedipine—CALM1—Disease—MDM2—muscle cancer	8.13e-06	0.000155	CbGpPWpGaD
Nifedipine—CALM3—Disease—PTGS2—muscle cancer	8.1e-06	0.000155	CbGpPWpGaD
Nifedipine—CALM2—Disease—PTGS2—muscle cancer	7.84e-06	0.00015	CbGpPWpGaD
Nifedipine—CALM1—Disease—PTGS2—muscle cancer	7.84e-06	0.00015	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—KIT—muscle cancer	7.47e-06	0.000143	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—KIT—muscle cancer	7.23e-06	0.000138	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—KIT—muscle cancer	7.23e-06	0.000138	CbGpPWpGaD
Nifedipine—CYP2B6—Metabolism—PTGS2—muscle cancer	6.97e-06	0.000133	CbGpPWpGaD
Nifedipine—CYP2E1—Metabolism—PTGS2—muscle cancer	6.83e-06	0.000131	CbGpPWpGaD
Nifedipine—CYP3A5—Metabolism—PTGS2—muscle cancer	6.81e-06	0.00013	CbGpPWpGaD
Nifedipine—CALM3—Metabolism—PTGS2—muscle cancer	6.78e-06	0.00013	CbGpPWpGaD
Nifedipine—CALM2—Metabolism—PTGS2—muscle cancer	6.56e-06	0.000125	CbGpPWpGaD
Nifedipine—CALM1—Metabolism—PTGS2—muscle cancer	6.56e-06	0.000125	CbGpPWpGaD
Nifedipine—CYP1A1—Metabolism—PTGS2—muscle cancer	6.44e-06	0.000123	CbGpPWpGaD
Nifedipine—CYP2C8—Metabolism—PTGS2—muscle cancer	5.9e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—MDM2—muscle cancer	5.88e-06	0.000113	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—MDM2—muscle cancer	5.69e-06	0.000109	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—MDM2—muscle cancer	5.69e-06	0.000109	CbGpPWpGaD
Nifedipine—ABCB1—Metabolism—PTGS2—muscle cancer	5.14e-06	9.83e-05	CbGpPWpGaD
Nifedipine—CYP2D6—Metabolism—PTGS2—muscle cancer	4.85e-06	9.26e-05	CbGpPWpGaD
Nifedipine—CYP2C9—Metabolism—PTGS2—muscle cancer	4.8e-06	9.18e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—VEGFA—muscle cancer	4.47e-06	8.54e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—VEGFA—muscle cancer	4.32e-06	8.27e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—VEGFA—muscle cancer	4.32e-06	8.27e-05	CbGpPWpGaD
Nifedipine—CYP1A2—Metabolism—PTGS2—muscle cancer	4.1e-06	7.85e-05	CbGpPWpGaD
Nifedipine—CALM3—Signaling Pathways—TP53—muscle cancer	3.38e-06	6.46e-05	CbGpPWpGaD
Nifedipine—CALM2—Signaling Pathways—TP53—muscle cancer	3.27e-06	6.25e-05	CbGpPWpGaD
Nifedipine—CALM1—Signaling Pathways—TP53—muscle cancer	3.27e-06	6.25e-05	CbGpPWpGaD
Nifedipine—CYP3A4—Metabolism—PTGS2—muscle cancer	3.17e-06	6.06e-05	CbGpPWpGaD
